📰 Bxrx News
Page 2 - Bxrx News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bxrx. Real-time updates on events, politics, business and more.
July 17, 2023
Baudax Bio, Inc. (NASDAQ:BXRX – Get Free Report) was the recipient of a significant increase in short interest during the month of June. As of June 30th, there was short interest totalling 50,100 shares, an increase of 347.3% from the June 15th total of 11,200 shares. Based on an average daily trading volume, of 2,870,000 […]
June 16, 2023
Baudax Bio, Inc. (NASDAQ:BXRX – Get Rating) saw a significant decrease in short interest in the month of May. As of May 31st, there was short interest totalling 59,800 shares, a decrease of 32.0% from the May 15th total of 88,000 shares. Currently, 2.3% of the shares of the stock are short sold. Based on […]
May 1, 2023
Baudax Bio (NASDAQ:BXRX – Get Rating) is scheduled to be announcing its earnings results on Tuesday, May 2nd. Baudax Bio (NASDAQ:BXRX – Get Rating) last announced its quarterly earnings data on Thursday, February 23rd. The company reported ($12.33) earnings per share (EPS) for the quarter. The company had revenue of $0.31 million for the quarter, […]
April 15, 2023
Baudax Bio, Inc. (NASDAQ:BXRX – Get Rating) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 204,800 shares, an increase of 369.7% from the March 15th total of 43,600 shares. Based on an average daily volume of 1,230,000 shares, the short-interest ratio is […]
June 12, 2022
Baudax Bio, Inc. (NASDAQ:BXRX – Get Rating) was the recipient of a significant increase in short interest in May. As of May 31st, there was short interest totalling 305,900 shares, an increase of 116.3% from the May 15th total of 141,400 shares. Based on an average daily volume of 300,700 shares, the days-to-cover ratio is […]
June 12, 2022
Baudax Bio (NASDAQ:BXRX – Get Rating) and Marpai (NASDAQ:MRAI – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings and institutional ownership. Earnings & Valuation This table compares Baudax Bio and Marpai’s […]
May 17, 2022
Baudax Bio, Inc. (NASDAQ:BXRX – Get Rating) was the recipient of a large decline in short interest in the month of April. As of April 30th, there was short interest totalling 188,100 shares, a decline of 19.4% from the April 15th total of 233,500 shares. Based on an average daily trading volume, of 443,200 shares, […]
March 23, 2022
Zacks Investment Research upgraded shares of Baudax Bio (NASDAQ:BXRX – Get Rating) from a hold rating to a buy rating in a research report sent to investors on Tuesday morning, Zacks.com reports. The firm currently has $2.25 target price on the stock. According to Zacks, “Baudax Bio Inc. is a pharmaceutical company. It is focused […]